Sequana Health is a Cambridge-based biotech company serving both the academic community and industry by providing genome editing systems. Our goal is two-fold: make current CRISPR-cas9/cpf1 systems more accessible and create novel genome editing platforms for a broader spectrum of applications. We have developed cortical and deep learning-based approaches to aid this goal. We identified high quality targets with low off-target effects, high sequence specificity, and high effectiveness of targeting multiple isoforms. We also developed novel editing systems that differ from the current Broad/Berkeley cas systems. We are thrilled to release them soon.
Human genome editing tools are just the beginning. We will expand to other spheres of bioengineering including agriculture, therapeutics, among others. Our vision is to help mankind fight off disease and digitize bioscience.